Skip to main content
The Flux Daily
HealthUnited States

New Strain of Mpox Identified in California: Implications and Responses

The first U.S. case of a novel mpox strain emerges, prompting health officials to assess the situation.

Source: bbc.co.uk2 min read
New Strain of Mpox Identified in California: Implications and Responses
Image via bbc.co.uk

In brief

California's health department has confirmed the first U.S. instance of the Clade I strain of mpox, linked to recent travel and an ongoing outbreak in Africa, raising concerns and prompting isolation protocols for the infected individual.

The state of California has officially reported the first case of a new emerging strain of mpox, known formally as monkeypox, marking a significant development in the ongoing fight against this virus. According to the California Department of Public Health (CDPH), the infected person recently traveled to regions in Africa where the Clade I strain is currently prevalent. This variant, distinct from the Clade II strain familiar to the U.S. since 2022, highlights the continued evolution of mpox around the globe.This patient is now in isolation at their home to prevent any potential spread of the virus. The CDPH has traced the case back to Clade I mpox outbreaks specifically identified in Central and Eastern African territories. Earlier this year, the World Health Organization classified mpox as a global health emergency, further emphasizing the need for vigilance against this virus.Notably, past data suggests that Clade I cases have historically led to more severe health issues than the Clade II strain; however, recent reports indicate that infections caused by Clade I might not present as serious symptoms as seen in previous outbreaks. Mpox is caused by a virus closely related to the smallpox virus, though it typically poses less of a threat.Initially zoonotic, this infection can now spread human-to-human, leading to symptoms like fever, fatigue, swollen lymph nodes, and muscle pain. Eventually, a rash may develop that can be both intensely itchy and painful. While the infection often resolves within about two to three weeks—sometimes with severe consequences for certain vulnerable populations—the potential for fatalities, especially among young children, remains a concern.In Africa, particularly in remote villages and regions like the Democratic Republic of Congo, mpox has been an ongoing issue, contributing to hundreds of deaths during earlier outbreaks this year. Although vaccines can help manage the spread of mpox, availability remains limited primarily to high-risk populations. As the situation unfolds and more cases potentially arise, health authorities will continue to monitor and respond to the challenges presented by this emerging mpox strain.

Topics

More on this story